Ra Capital Biotech Fund Ii, L.p. - Net Worth and Insider Trading
Ra Capital Biotech Fund Ii, L.p. Net Worth
The estimated net worth of Ra Capital Biotech Fund Ii, L.p. is at least $102 dollars as of 2024-11-13. Ra Capital Biotech Fund Ii, L.p. is the 10% Owner of Aradigm Corp and owns about 2,225 shares of Aradigm Corp (ARDMQ) stock worth over $102. Details can be seen in Ra Capital Biotech Fund Ii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ra Capital Biotech Fund Ii, L.p. has not made any transactions after 2007-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ra Capital Biotech Fund Ii, L.p.
Ra Capital Biotech Fund Ii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ra Capital Biotech Fund Ii, L.p. owns 4 companies in total, including BioSpecifics Technologies Corp (BSTC) , Aradigm Corp (ARDMQ) , and Sequenom Inc (SQNM) among others .
Insider Ownership Summary of Ra Capital Biotech Fund Ii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BSTC | BioSpecifics Technologies Corp | 2009-04-24 | 10 percent owner |
| ARDMQ | Aradigm Corp | 2008-10-29 | 10 percent owner |
| SQNM | Sequenom Inc | 2008-07-10 | 10 percent owner |
 | | 2007-08-08 | 10 percent owner |
Ra Capital Biotech Fund Ii, L.p. Latest Holdings Summary
Ra Capital Biotech Fund Ii, L.p. currently owns a total of 1 stock. Ra Capital Biotech Fund Ii, L.p. owns 2,225 shares of Aradigm Corp (ARDMQ) as of March 1, 2007, with a value of $102.
Latest Holdings of Ra Capital Biotech Fund Ii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARDMQ | Aradigm Corp | 2007-03-01 | 2,225 | 0.05 | 102 |
Holding Weightings of Ra Capital Biotech Fund Ii, L.p.
Ra Capital Biotech Fund Ii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Ra Capital Biotech Fund Ii, L.p. has made a total of 0 transactions in Aradigm Corp (ARDMQ) over the past 5 years. The most-recent trade in Aradigm Corp is the sale of 0 shares on March 1, 2007, which brought Ra Capital Biotech Fund Ii, L.p. around $0.
Insider Trading History of Ra Capital Biotech Fund Ii, L.p.
- 1
Ra Capital Biotech Fund Ii, L.p. Trading Performance
Ra Capital Biotech Fund Ii, L.p. Ownership Network
Ownership Network List of Ra Capital Biotech Fund Ii, L.p.
Ownership Network Relation of Ra Capital Biotech Fund Ii, L.p.
Ra Capital Biotech Fund Ii, L.p. Owned Company Details
What does BioSpecifics Technologies Corp do?
Who are the key executives at BioSpecifics Technologies Corp?
Ra Capital Biotech Fund Ii, L.p. is the 10 percent owner of BioSpecifics Technologies Corp. Other key executives at BioSpecifics Technologies Corp include director & 10 percent owner Toby Wegman , director & Chief Executive Officer Joseph Truitt , and Chief Financial Officer Patrick Hutchison .
BioSpecifics Technologies Corp (BSTC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of BioSpecifics Technologies Corp (BSTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioSpecifics Technologies Corp (BSTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
BioSpecifics Technologies Corp (BSTC)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioSpecifics Technologies Corp Insider Transactions
Ra Capital Biotech Fund Ii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Ra Capital Biotech Fund Ii, L.p.. You might contact Ra Capital Biotech Fund Ii, L.p. via mailing address: 800 Boylston Street, Suite 1500, Boston Ma 02199.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
